The other checkpoint molecule, PD-L1, is expressed on normal and cancer cells and appears to release inhibitory signals upon its interaction with its receptor PD-1 on T cells and thereby weakens their reactivity (17, 23). This evidence concerns the gene CD274 and cancer.